Industry Spotlight

Sector concern over scrapping of 457 visas

20 April 2017 via Biotech Dispatch: Questions across the life sciences sector after the Turnbull government announced major changes to section 457 visas for temporary skilled migrants. In immediate changes, a number of occupations important to the life sciences sect... | READ MORE

IP Australia delays legislation

20 April 2017 via Biotech Dispatch: Government will not proceed with legislation designed to align and streamline the processes for obtaining, maintaining and challenging intellectual property rights, pending its response to last years Productivity Commission report ... | READ MORE

Extended deployment for Alcidion’s Patient Flow Solution

18 April 2017 via Biotech Dispatch: The Northern Territory Department of Health has extended their relationship with Alcidion (ASX:ALC) with deployment of the companys Patient Flow Solution throughout Katherine Hospital. According to the company, its Miya platform p... | READ MORE

Immuron announces positive results of IMM-124E in acute colitis

18 April 2017 via Biotech Dispatch: Immuron (ASX:IMC) has announced it has successfully completed the first stage of its colitis preclinical program at the University of Zurich in Switzerland. The company said it is preparing to move forward to the next development ... | READ MORE

IDT reports better than expected sales result

13 April 2017 via Biotech Dispatch: IDT Australia has reported better than expected sales following the recent US launch of its generic temozolomide. The company received FDA approval for its internally developed temozolomide brand in April 2016. Read more in Biote... | READ MORE

Applications open for Bridge Program

13 April 2017 via Biotech Dispatch: Expressions of interest are now open for the Bridge Program. The Program, a consortium of 14 partners including global life sciences companies, venture capitalists, universities and industry associations, will be launched by QUT i... | READ MORE

New digital collaboration to back connected medical technologies

11 April 2017 via Biotech Dispatch: Companies working to improve health outcomes for patients via digital and connected medical technologies have a new support organisation following the launch of ANDHealth - a national initiative funded through the MTPConnect Projec... | READ MORE

Government grant for Cell Therapies

11 April 2017 via Biotech Dispatch: Cell Therapies is one of nine companies to share in $8.69 million in funding under the Turnbull governments Global Innovation Linkages programme (GIL). ;Cell Therapies, together with global partners in the US, has been granted $1 m... | READ MORE

BARD1 Life Sciences announces new collaboration

6 April 2017 via Biotech Dispatch: BARD1 Life Sciences (ASX:BD1) has entered into a collaboration with the Institute for Respiratory Health (IRH) to evaluate a BARD1 cancer vaccine for the prevention and/or treatment of cancer in animal models. Read more in Biotech ... | READ MORE

Opthea reports positive trial results for OPT-302

6 April 2017 via Biotech Dispatch: Opthea (ASX:OPT), a developer of novel biologic therapies for the treatment of eye diseases, has announced what it describes as positive results from its Phase 1/2A clinical trial of OPT-302, a novel VEGF-C/D Trap therapy for wet ag... | READ MORE

Previous page | Next page
Jump to page